+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dydrogesterone Market by Form, Route of Administration, Product Type, Distribution Channel, Indication, Dosage Strength - Global Forecast to 2030- Product Image
Dydrogesterone Market by Form, Route of Administration, Product Type, Distribution Channel, Indication, Dosage Strength - Global Forecast to 2030- Product Image
Sale

Dydrogesterone Market by Form, Route of Administration, Product Type, Distribution Channel, Indication, Dosage Strength - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083722
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The dydrogesterone market is strengthening its position in women’s health therapeutics, propelled by a blend of pharmacological innovation and evolving clinical demand. Senior executives seeking actionable insights will find that emerging technologies and dynamic regional strategies are shaping the path forward for both established and new market entrants.

Market Snapshot: Dydrogesterone Market Overview

The dydrogesterone market grew from USD 618.12 million in 2024 to USD 679.57 million in 2025, and is projected to reach USD 1.07 billion by 2030 at a CAGR of 9.57%. This robust expansion reflects increasing adoption in gynecological care, strong clinical validation, and broadened distribution by global pharmaceutical and regional companies. Dydrogesterone is utilized prominently for conditions like endometriosis, menstrual irregularities, and fertility protocols, continually gaining acceptance from healthcare providers. The market is shaped by differentiated formulations, regulatory advancements, and a competitive landscape featuring both branded and generic solutions.

Scope & Segmentation

This report delivers comprehensive analysis built around dedicated market segments, regional variations, and stakeholder strategies.

  • Form: Capsule, Injection, Tablet
  • Route Of Administration: Oral, Parenteral
  • Product Type: Branded, Generic
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Indication: Endometriosis, Infertility, Menstrual Bleeding Disorders
  • Dosage Strength: Ten Mg, Twenty Mg
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with countries such as United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, and more)
  • Companies Analyzed: Abbott Laboratories, Mankind Pharma Private Limited, Dr. Reddy’s Laboratories Limited, Sun Pharmaceutical Industries Limited, Cipla Limited, Teva Pharmaceutical Industries Limited, Pfizer Inc., Lupin Limited, Intas Pharmaceuticals Limited, Zydus Lifesciences Limited

Key Takeaways for Strategic Decision-Makers

  • High adoption rates in both developed and emerging healthcare markets are attributed to dydrogesterone’s clinical profile and formulary versatility.
  • Pharmaceutical alliances and distributive innovation continue to enhance patient accessibility and support the rapid uptake of both established and new therapies.
  • Formulation choice impacts care delivery: capsules are favored for convenience and familiarity, while injectables appeal to hospital-based and acute care settings.
  • A surge in generic competition is intensifying price pressures, positioning value-based approaches and patient support programs as major competitive differentiators.
  • Diverse regional infrastructures influence demand trajectories, with private healthcare in Asia-Pacific and public health agendas in Latin America driving notable market growth.
  • Effective inventory strategies and responsive supply chain operations are critical amidst ongoing regulatory shifts and uncertainty in international logistics.

Impact of United States Tariffs on Supply Chain Dynamics

New U.S. tariffs introduced in 2025 have added cost and operational complexity to global supply chains. Manufacturers are adapting with dual sourcing strategies, enhanced local production, and renegotiated distribution agreements that factor in higher freight expenses and inventory adjustments. These responses are central for maintaining consistent product availability and mitigating upstream cost escalation for healthcare providers and patients.

Rigorous Methodology & Reliable Data Sources

This report’s findings are anchored by systematic secondary research, including regulatory documents and clinical literature, triangulated across multiple sources for accuracy. Primary research comprised expert interviews with clinicians, procurement professionals, and policy specialists, as well as targeted quantitative surveys. Analytical modeling incorporated real-time intelligence from raw material supply through to distribution economics.

Why This Report Matters

  • Empowers senior stakeholders to benchmark evolving commercial strategies and adapt to regional market realities.
  • Provides evidence-based segmentation analysis supporting investment, partnership, and positioning decisions across the value chain.
  • Enables the development of risk-mitigated supply and pricing models suited to the new regulatory and economic landscape.

Conclusion

By mapping the competitive and operational evolution of the dydrogesterone market, this report equips leaders with insight to refine planning, support robust commercialization, and align with emerging healthcare priorities. Forward-looking strategies will benefit from a nuanced understanding of clinical adoption and region-specific opportunities.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dydrogesterone Market, by Form
8.1. Introduction
8.2. Capsule
8.3. Injection
8.4. Tablet
9. Dydrogesterone Market, by Route of Administration
9.1. Introduction
9.2. Oral
9.3. Parenteral
10. Dydrogesterone Market, by Product Type
10.1. Introduction
10.2. Branded
10.3. Generic
11. Dydrogesterone Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Dydrogesterone Market, by Indication
12.1. Introduction
12.2. Endometriosis
12.3. Infertility
12.4. Menstrual Bleeding Disorders
13. Dydrogesterone Market, by Dosage Strength
13.1. Introduction
13.2. Ten Mg
13.3. Twenty Mg
14. Americas Dydrogesterone Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Dydrogesterone Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Dydrogesterone Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Mankind Pharma Private Limited
17.3.3. Dr. Reddy’s Laboratories Limited
17.3.4. Sun Pharmaceutical Industries Limited
17.3.5. Cipla Limited
17.3.6. Teva Pharmaceutical Industries Limited
17.3.7. Pfizer Inc.
17.3.8. Lupin Limited
17.3.9. Intas Pharmaceuticals Limited
17.3.10. Zydus Lifesciences Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DYDROGESTERONE MARKET MULTI-CURRENCY
FIGURE 2. DYDROGESTERONE MARKET MULTI-LANGUAGE
FIGURE 3. DYDROGESTERONE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DYDROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DYDROGESTERONE MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DYDROGESTERONE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DYDROGESTERONE MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DYDROGESTERONE MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DYDROGESTERONE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DYDROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DYDROGESTERONE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DYDROGESTERONE MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DYDROGESTERONE MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DYDROGESTERONE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DYDROGESTERONE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DYDROGESTERONE MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DYDROGESTERONE MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DYDROGESTERONE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DYDROGESTERONE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DYDROGESTERONE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DYDROGESTERONE MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DYDROGESTERONE MARKET SIZE, BY INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DYDROGESTERONE MARKET SIZE, BY MENSTRUAL BLEEDING DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DYDROGESTERONE MARKET SIZE, BY TEN MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DYDROGESTERONE MARKET SIZE, BY TWENTY MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. CANADA DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 42. CANADA DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. CANADA DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. CANADA DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 47. MEXICO DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 48. MEXICO DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. MEXICO DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. MEXICO DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 73. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 78. GERMANY DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 79. GERMANY DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. GERMANY DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. GERMANY DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. GERMANY DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. GERMANY DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 84. FRANCE DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 85. FRANCE DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. FRANCE DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. FRANCE DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. FRANCE DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. FRANCE DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 90. RUSSIA DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 91. RUSSIA DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. RUSSIA DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. RUSSIA DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 96. ITALY DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 97. ITALY DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. ITALY DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. ITALY DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. ITALY DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 102. SPAIN DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 103. SPAIN DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. SPAIN DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. SPAIN DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. SPAIN DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. SPAIN DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 108. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 109. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 114. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 115. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 120. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 126. DENMARK DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 127. DENMARK DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. DENMARK DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. DENMARK DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. DENMARK DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 138. QATAR DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 139. QATAR DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. QATAR DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. QATAR DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. QATAR DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. QATAR DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 144. FINLAND DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 145. FINLAND DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. FINLAND DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. FINLAND DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. FINLAND DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. FINLAND DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 150. SWEDEN DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 151. SWEDEN DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. SWEDEN DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. SWEDEN DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 156. NIGERIA DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 157. NIGERIA DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. NIGERIA DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 162. EGYPT DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 163. EGYPT DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. EGYPT DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. EGYPT DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 167. EGYPT DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 168. TURKEY DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 169. TURKEY DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. TURKEY DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. TURKEY DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. TURKEY DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 173. TURKEY DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 174. ISRAEL DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 175. ISRAEL DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. ISRAEL DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 180. NORWAY DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 181. NORWAY DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. NORWAY DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. NORWAY DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. NORWAY DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 185. NORWAY DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 186. POLAND DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 187. POLAND DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. POLAND DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. POLAND DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. POLAND DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. POLAND DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 192. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 193. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 205. CHINA DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 206. CHINA DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. CHINA DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. CHINA DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. CHINA DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 210. CHINA DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 211. INDIA DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 212. INDIA DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 213. INDIA DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. INDIA DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. INDIA DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 216. INDIA DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 217. JAPAN DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 218. JAPAN DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 219. JAPAN DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. JAPAN DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. JAPAN DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 222. JAPAN DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 241. THAILAND DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 242. THAILAND DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 243. THAILAND DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. THAILAND DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. THAILAND DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 246. THAILAND DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 265. VIETNAM DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 266. VIETNAM DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 267. VIETNAM DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN DYDROGESTERONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN DYDROGESTERONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN DYDROGESTERONE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN DYDROGESTERONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN DYDROGESTERONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN DYDROGESTERONE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 277. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 278. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Dydrogesterone market report include:
  • Abbott Laboratories
  • Mankind Pharma Private Limited
  • Dr. Reddy’s Laboratories Limited
  • Sun Pharmaceutical Industries Limited
  • Cipla Limited
  • Teva Pharmaceutical Industries Limited
  • Pfizer Inc.
  • Lupin Limited
  • Intas Pharmaceuticals Limited
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 679.57 Million
Forecasted Market Value ( USD ) by 2030 $ 1070 Million
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Dydrogesterone: 2017 Global and Regional Analysis and Forecast to 2022 - Product Image

Dydrogesterone: 2017 Global and Regional Analysis and Forecast to 2022

  • Report
  • 55 Pages
  • Global
From
Dydrogesterone (CAS 152-62-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Dydrogesterone (CAS 152-62-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Lifestyle Drugs Market by Indication, Distribution Channel, Dosage Form, Route of Administration, End User, Therapeutic Class - Global Forecast to 2030 - Product Image

Lifestyle Drugs Market by Indication, Distribution Channel, Dosage Form, Route of Administration, End User, Therapeutic Class - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Carbetocin Market by Indication, Formulation, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Carbetocin Market by Indication, Formulation, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From

About the Dydrogesterone Market

Dydrogesterone is a synthetic progestogen used in the treatment of sexual and reproductive health conditions. It is used to treat a variety of conditions, including endometriosis, premenstrual syndrome, and infertility. It is also used to support pregnancy and to prevent miscarriage. Dydrogesterone is available in both oral and injectable forms. It is generally well tolerated, with few side effects. Dydrogesterone is used in combination with other drugs to treat a variety of sexual and reproductive health conditions. It is often used in combination with estrogens to treat endometriosis and premenstrual syndrome. It is also used in combination with other drugs to treat infertility and to support pregnancy. The market for dydrogesterone is growing, driven by increasing awareness of sexual and reproductive health conditions and the need for effective treatments. The market is expected to continue to grow in the coming years. Some companies in the dydrogesterone market include Mylan, Sun Pharmaceuticals, Lupin, and Cipla. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.